Total Funding
79
74
Total FundingSeries B raised
Growth Score 79 in past quarter
-6 pts
Heat Score 74 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
53763
INDIGO Biosciences offers products and services on nuclear receptors, which comprise of therapeutic drug targets.
- Bob Culhane: CFO
Jack Vanden Heuvel: Chief Scientific Officer
About the Company
INDIGO Biosciences supplements the receptor assay kits and services and in vitro toxicology solutions with greater readability, reproducibility, and faster turnaround times of the results. Their solutions, combined with a supportive team and reliable science and platforms, aim to reduce the time, cost, and risk associated with the discovery
process.
